Citius Pharmaceuticals Inc (CTXR) Company Profile & Statistics

Citius Pharmaceuticals Inc
CTXR
(Nasdaq - US)
Closed
3.27
-0.33 (-9.17%)
in:usd•As of: Nov 29, 2024 14:45 UTC -5
Open
3.47
High
3.47
Low
3.24

About Citius Pharmaceuticals Inc

CEO

Leonard Mazur

Headquarters

11 commerce drive, first floor

cranford, nj 07016, united states

Auditor

Wolf & Company, P.C.

Employees

Share Holders

Website

www.citiuspharma.com

Industry

medical specialties

Sector

health technology

Company Overview

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care and prescription products. Citius Pharmaceuticals, Inc. is headquartered in Cranford, New Jersey.

Citius Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	590.99M
Enterprise Value	573.08M
Enterprise Value/EBITDA (ttm)	-14.02
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.30
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-44.65%
Return on Invested Capital (ttm)	-44.63%
Return on Assets (ttm)	-39.39%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-40.86M
Net Income Avi to Common (ttm)	-39.77M
Diluted EPS (ttm)	-6.00

Share Statistics

Beta (5Y Monthly)	1.66
52-Week Change	326.23%
S&P500 52-Week Change	32.06%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	180.73M
Dividend Yield	0.00%
Float ⁴	6.14M
% Held by Insiders	15.00%
% Held by Institutions	16.88%

Balance Sheet

Total Cash (mrq)	17.91M
Total Cash Per Share (mrq)	0.10
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	6.75%
Quick Ratio (mrq)	6.75%
Book Value Per Share (mrq)	0.48

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.13
Free Cash Flow (ytd)	-22.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Citius Pharmaceuticals Inc

Trade With A Regulated Broker